Navigation Links
Cancer vaccine combination therapy shows survival benefit in breast cancer
Date:5/15/2012

(SACRAMENTO, Calif.) A vaccine that targets cancer cells in combination with the drug letrozole, a standard hormonal therapy against breast cancer, significantly increased survival when tested in mice, a team of UC Davis investigators has found.

The findings will be published today in the journal Clinical Cancer Research.

"We found that the vaccine and the hormonal drug letrozole were more effective when given together," said Michael DeGregorio, UC Davis professor of hematology and oncology and principal investigator of the study. "This adds critical evidence that immunotherapy with vaccines, which has traditionally been used to prevent infectious diseases, is also a promising new approach to combating cancer."

The vaccine, known as L-BLP25 (Stimuvax), specifically targets Mucin1 glycoprotein (MUC1), an antigen that is expressed in an altered form on cancer cells. When introduced into the body, the vaccine generates an immune response by T-lymphocytes, which then recognize and destroy the tumor cells. Mice in the study were injected weekly with the vaccine -- or a placebo -- for eight weeks.

In addition to the vaccine or placebo, some mice were treated with either letrozole or tamoxifen, commonly used hormonal therapies against breast cancer. Both drugs work by blocking the effects of estrogen, which can slow or stop the growth of some types of breast cancer cells that need the hormone to grow. Although the drugs have similar actions, the benefits of the vaccine were greatest in the mice treated with letrozole; in contrast, vaccinated mice given tamoxifen actually fared worse than those given either the vaccine or tamoxifen alone.

"Hormonal drugs affect the immune system in different ways, and apparently the actions of tamoxifen prevent the vaccine from working effectively," said DeGregorio. "This highlights the importance of rigorous testing of different combinations of therapies before using them in pa
'/>"/>

Contact: Dorsey Griffith
dorsey.griffith@ucdmc.ucdavis.edu
916-734-9118
University of California - Davis Health System
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Study highlights need for coordination of care in stage 2 and 3 rectal cancer treatment
2. John Theurer Cancer Center hosting 8th Annual Neuro-Oncology Symposium
3. Study examines BI-RADS and MRI in predicting breast cancer
4. Early biomarker for pancreatic cancer identified
5. Fertilizing bone marrow helps answer why some cancers spread to bones
6. Genetic test identifies eye cancer tumors likely to spread
7. Scientists make breakthrough in bile duct cancer with discovery of new gene mutations
8. Drug kills cancer cells by restoring faulty tumor suppressor
9. Mayo Clinic researchers discover biomarkers for prostate cancer detection, recurrence
10. Common Blood Pressure Drugs May Not Cut Colon Cancer Risk
11. Blood pressure drugs dont protect against colorectal cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... (PRWEB) December 26, 2014 “Many people ... with personal injury claim issues and phone calls with ... released an article featuring their free eBook on ... helpful eBook on pedestrian and bicycle auto accident claims ... is fully capable of professionally handling their case while ...
(Date:12/25/2014)... The microscopy market is estimated to grow at ... by 2019. Optical microscopy is the largest segment ... segment is expected to show the fastest growth ... nanotechnology, technological advancements, and increasing federal support to ... Full Copy of Report @ http://www.marketsandmarkets.com/Market-Reports/world-microscopy-399.html ...
(Date:12/25/2014)... York, New York (PRWEB) December 25, 2014 ... the 2010 DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) ... LLP reports. According to an Order issued in the ... 20th, the Court will convene an open conference on ... Building and United States Courthouse in West Palm Beach, ...
(Date:12/25/2014)... Recently, BellasDress has launched ... wedding dresses. BellasDress has chosen their best-selling lace wedding ... for the holiday season. , Now, BellasDress.com features ... gowns here at discount prices. The business hopes everyone ... website. , “All our elegant products are ...
(Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. ... chronic illnesses can receive effective, less expensive care from a ... to a team of dedicated health care professionals, a new ... ill and need either hospitalization or a trip to the ... home clinic at the University of Texas in Houston versus ...
Breaking Medicine News(10 mins):Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3
... workers has suggested that the workplace may play// an important ... current study examined the role of occupational workplace and the ... physical activity and irregular food intake are some of the ... seeing a rise in the occurrence of some of the ...
... In a unique initiative a railway station – Ongole town ... announcement system to not only broadcast arrival and departures of ... the need for safe sex. Andhra Pradesh in India has ... 50-year-old porter "The current generation is racing towards HIV/AIDS like ...
... whose mothers during pregnancy consumed// low-mercury fish couple of ... those mothers who did not. ,Conversely it ... mercury content lowered the intelligence score. ,The study ... intake of their mothers during pregnancy. ,Data revealed ...
... end-stage lung cancer who were given Tarceva lived longer than ... common cancer occurring both in men and women. Two studies ... from all over the world. ,The first study was ... conducted his study in 482 patients. The study was done ...
... of sleeping less may be due to other reasons// than age ... that had been associated with increased age for the elderly population ... findings of the research show that there may be other factors ... the geriatric people. ,The research findings point to five ...
... effective in detecting blocked// carotid artery that may increase ... Virginia Commonwealth University School of Dentistry have reported that ... health of the patient can show some cases of ... patient. ,The dentists to observe the entire ...
Cached Medicine News:Health News:Drug Tarceva for End-stage Lung cancer 2
(Date:12/24/2014)... 24, 2014  Conkwest, Inc., the Natural Killer ... Natural Killer (NK) cell-line platform, Neukoplast® (NK-92™) as ... Soon-Shiong , NantWorks founder, physician scientist and biotechnology ... purchase approximately $48 million of the Company,s Class ... he will be named Co-Chairman of the Conkwest ...
(Date:12/24/2014)... -- Echo Therapeutics, Inc. (NASDAQ: ECTE ... permeation, continuous glucose monitoring and associated technologies, today ... been appointed Chief Executive Officer effective December 22, ... of experience in the medical device, pharmaceutical and ... Vice President, Business Development, Otsuka Pharmaceuticals as well as ...
(Date:12/24/2014)... , Dec. 23, 2014   Assurex Health, ... support to healthcare providers for behavioral health and ... secured $30 million in equity financing from new ... Drosos , President and Chief Executive Officer. ... and development of Assurex Health,s GeneSight ® ...
Breaking Medicine Technology:Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4
... WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS ), a ... will present an overview of the company at the 13th annual ... Waldorf Astoria Hotel, Tuesday, February 15, 2011 at 11:30 a.m. Eastern ... days and may be accessed at www.wafergen.com . ...
... Ill., Feb. 2, 2011 Hospira, Inc. (NYSE: ... company, today reported results for the fourth quarter and full ... 2010, net sales were $992 million, and adjusted* diluted earnings ... $3.9 billion, and adjusted* diluted earnings per share were $3.31. ...
Cached Medicine Technology:WaferGen to Present at 13th Annual BIO CEO and Investor Conference 2Hospira Reports Fourth-Quarter and Full-Year 2010 Results 2Hospira Reports Fourth-Quarter and Full-Year 2010 Results 3Hospira Reports Fourth-Quarter and Full-Year 2010 Results 4Hospira Reports Fourth-Quarter and Full-Year 2010 Results 5Hospira Reports Fourth-Quarter and Full-Year 2010 Results 6Hospira Reports Fourth-Quarter and Full-Year 2010 Results 7Hospira Reports Fourth-Quarter and Full-Year 2010 Results 8Hospira Reports Fourth-Quarter and Full-Year 2010 Results 9Hospira Reports Fourth-Quarter and Full-Year 2010 Results 10Hospira Reports Fourth-Quarter and Full-Year 2010 Results 11Hospira Reports Fourth-Quarter and Full-Year 2010 Results 12Hospira Reports Fourth-Quarter and Full-Year 2010 Results 13Hospira Reports Fourth-Quarter and Full-Year 2010 Results 14Hospira Reports Fourth-Quarter and Full-Year 2010 Results 15Hospira Reports Fourth-Quarter and Full-Year 2010 Results 16Hospira Reports Fourth-Quarter and Full-Year 2010 Results 17Hospira Reports Fourth-Quarter and Full-Year 2010 Results 18Hospira Reports Fourth-Quarter and Full-Year 2010 Results 19
...
Medtronic neurosurgery external drainage and monitoring (EDM) products meet a variety of needs for CSF drainage and monitoring....
... Catheter system is a technically ... external CSF drainage which reduces ... tube surfaces. Treated with the ... it reduces the potential for ...
Cruchfield Skull Traction Tong, small pattern....
Medicine Products: